BRPI0410074A - compostos, processo para a preparação e uso dos mesmos, composição, e, processo para o incremento da produção de colágeno e/ou elastina na pele humana e/ou para o retardamento ou o tratamento do envelhecimento da pele - Google Patents

compostos, processo para a preparação e uso dos mesmos, composição, e, processo para o incremento da produção de colágeno e/ou elastina na pele humana e/ou para o retardamento ou o tratamento do envelhecimento da pele

Info

Publication number
BRPI0410074A
BRPI0410074A BRPI0410074-3A BRPI0410074A BRPI0410074A BR PI0410074 A BRPI0410074 A BR PI0410074A BR PI0410074 A BRPI0410074 A BR PI0410074A BR PI0410074 A BRPI0410074 A BR PI0410074A
Authority
BR
Brazil
Prior art keywords
processes
compounds
optionally substituted
production
elastin
Prior art date
Application number
BRPI0410074-3A
Other languages
English (en)
Inventor
Hugo Ziegler
Marc Heidl
Dominik Imfeld
Original Assignee
Pentapharm Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pentapharm Ag filed Critical Pentapharm Ag
Publication of BRPI0410074A publication Critical patent/BRPI0410074A/pt
Publication of BRPI0410074B1 publication Critical patent/BRPI0410074B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Detergent Compositions (AREA)

Abstract

"COMPOSTOS, PROCESSO PARA A PREPARAçãO E USO DOS MESMOS, COMPOSIçãO, E, PROCESSO PARA O INCREMENTO DA PRODUçãO DE COLáGENO E/OU ELASTINA NA PELE HUMANA E/OU PARA O RETARDAMENTO OU O TRATAMENTO DO ENVELHECIMENTO DA PELE". Compostos e sais cosmeticamente aceitáveis dos mesmos, que correspondem à fórmula geral (I) sendo que: R¬ 1¬ representa H, -C(O)-R¬ 6¬, -SO~ 2~-R¬ 6¬ ou -C(O)-XR¬ 6¬; R¬ 2¬ e R¬ 4¬ = independentemente um do outro, representam (CH~ 2~)~ n~,-NH~ 2~ ou (CH~ 2~)~ 3~NHC(NH)NH~ 2~; n = 1-4; R~ 3~ = C~ 1~-C~ 4~ -alquila linear ou ramificado opcionalmente substituído por hidroxila; R¬ 5¬ e R¬ 6¬ = independentemente um do outro, representam hidrogênio, (C~ 1~-C~ 24~)-alquila opcionalmente substituido, C~ 2-C~ 24~-alquenila opcionalmente substituído, fenila opcionalmente substituído, fenil-C~ 1~-C~ 4~-alquila opcionalmente substituído ou 9-fluorenilmetila; X = oxigênio (-O-) ou -NH-; ou XR 5¬ com X = O também representa os ésteres de <244>-tocoferol, tocotrienol ou retinol, com a condição de que R¬ 1¬ e R¬ 5¬ não representem hidrogênio e X não represente oxigênio ao mesmo tempo; a preparação dos compostos de fórmula geral (I); composição cosmeticamente ativa que compreende pelo menos um composto de fórmula (I).
BRPI0410074-3A 2003-05-08 2004-05-07 Compostos, processo para a preparação e uso dos mesmos, composição, e, processo para o incremento da produção de colágeno e/ou elastina na pele humana e/ou para o retardamento ou o tratamento do envelhecimento da pele BRPI0410074B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH8072003 2003-05-08
CH807/03 2003-05-08
PCT/CH2004/000278 WO2004099237A1 (de) 2003-05-08 2004-05-07 Tripeptide und deren derivate für die kosmetische verwendung zur verbesserung der hautstruktur

Publications (2)

Publication Number Publication Date
BRPI0410074A true BRPI0410074A (pt) 2006-05-23
BRPI0410074B1 BRPI0410074B1 (pt) 2020-03-10

Family

ID=33426270

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0410074-3A BRPI0410074B1 (pt) 2003-05-08 2004-05-07 Compostos, processo para a preparação e uso dos mesmos, composição, e, processo para o incremento da produção de colágeno e/ou elastina na pele humana e/ou para o retardamento ou o tratamento do envelhecimento da pele

Country Status (12)

Country Link
US (2) US7863417B2 (pt)
EP (1) EP1625150B9 (pt)
JP (2) JP4769709B2 (pt)
KR (1) KR101116528B1 (pt)
AT (1) ATE350389T1 (pt)
BR (1) BRPI0410074B1 (pt)
CA (1) CA2525476C (pt)
DE (1) DE502004002556D1 (pt)
ES (1) ES2280962T3 (pt)
PL (1) PL1625150T3 (pt)
RU (1) RU2346949C2 (pt)
WO (1) WO2004099237A1 (pt)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0410074B1 (pt) * 2003-05-08 2020-03-10 Dsm Ip Assets B.V. Compostos, processo para a preparação e uso dos mesmos, composição, e, processo para o incremento da produção de colágeno e/ou elastina na pele humana e/ou para o retardamento ou o tratamento do envelhecimento da pele
FR2870243B1 (fr) * 2004-05-11 2010-11-19 Centre Nat Rech Scient Conjugues tripeptidiques agonistes de la msh
FR2870244B1 (fr) 2004-05-11 2011-01-07 Centre Nat Rech Scient Conjugues dipeptidiques antagonistes de l'alpha-msh
US9616011B2 (en) 2005-04-27 2017-04-11 The Procter & Gamble Company Personal care compositions
AU2014271339B2 (en) * 2005-04-27 2016-11-03 The Procter & Gamble Company Personal care compositions
US20070020220A1 (en) * 2005-04-27 2007-01-25 Procter & Gamble Personal care compositions
ES2638242T3 (es) * 2006-02-16 2017-10-19 Sederma Polipéptidos KXK y su uso
ES2283212B1 (es) * 2006-03-31 2008-08-16 Lipotec S.A. Peptidos sinteticos utiles en el tratamiento de la piel y su uso en composiciones cosmeticas o dermofarmaceuticas.
BRPI0621609B1 (pt) * 2006-04-28 2017-12-19 Dsm Ip Assets B.V. Composition, non-therapeutic use of the composition and compounds
CN105288581A (zh) * 2006-06-01 2016-02-03 治疗剂肽有限公司 聚合生物表面活性剂
ES2322882B1 (es) * 2006-10-25 2010-04-22 Lipotec Sa Peptidos inhibidores de la exocitosis neuronal.
EP1992332A1 (en) 2007-05-08 2008-11-19 Tupperware Products S.A. Cosmetic anti ageing skin care compositions
CH696838A5 (it) * 2007-05-29 2007-12-31 Labo Cosprophar Ag Composizione cosmetica ad effetto lifting per sostenere tessuti cutanei rilassati.
EP2180027B1 (en) * 2007-07-05 2011-10-26 Nissan Chemical Industries, Ltd. Novel lipid-tripeptide based hydrogel-forming agent and hydrogel
CN102387772A (zh) * 2008-05-29 2012-03-21 唐纳德·欧文 皮肤美容组合物中的寡聚生物表面活性剂
EP2382231A2 (en) 2009-01-16 2011-11-02 Sederma New compounds, in particular peptides, compositions comprising them and cosmetic and dermopharmaceutical uses
FR2941232B1 (fr) 2009-01-16 2014-08-08 Sederma Sa Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
FR2941231B1 (fr) * 2009-01-16 2016-04-01 Sederma Sa Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
JP2012518606A (ja) * 2009-02-20 2012-08-16 ディーエスエム アイピー アセッツ ビー．ブイ． 新規組成物
CN102355885A (zh) * 2009-03-16 2012-02-15 帝斯曼知识产权资产管理有限公司 三肽的用途
JP5754053B2 (ja) 2009-04-22 2015-07-22 ディーエスエム アイピー アセッツ ビー．ブイ． 新規な組成物
WO2011052613A1 (ja) * 2009-10-26 2011-05-05 日産化学工業株式会社 化粧料及び皮膚外用剤、並びに医療用機器
KR101951916B1 (ko) * 2011-03-31 2019-02-25 닛산 가가쿠 가부시키가이샤 화장료의 제조방법, 화장료용 겔의 조제방법 및 화장료 원료에 배합되는 고분자 증점제의 사용량을 경감하는 방법
MX356540B (es) 2011-05-10 2018-06-01 Mary Kay Inc Composiciones cosmeticas.
KR101167285B1 (ko) * 2011-11-18 2012-07-23 에이앤펩주식회사 피부 미백 활성을 갖는 나이아신-펩타이드 및 그의 용도
JP6360437B2 (ja) * 2011-12-20 2018-07-18 ユニリーバー・ナームローゼ・ベンノートシヤープ アミノペプチド混合物を含む保湿組成物
DE102012210379A1 (de) * 2012-06-20 2013-12-24 Beiersdorf Ag Kosmetische und dermatologische Zubereitung enthaltend eine oder mehrere Substanz(en), die das Gen / Protein für den Rezeptor Endo180 modulieren
US20140135269A1 (en) * 2012-10-01 2014-05-15 Peter Thomas Roth Labs, Llc Peptide And Protein-Based Formula For Improving The Appearance Of Skin
JP6115086B2 (ja) * 2012-11-13 2017-04-19 味の素株式会社 アミノ酸化合物の酢酸塩を含有する化粧料組成物
CN105189531B (zh) 2013-03-13 2020-02-21 安特易斯有限公司 用于皮肤复新的肽及其使用方法
KR102647719B1 (ko) 2013-08-15 2024-03-14 마리 케이 인코포레이티드 주름 치료를 위한 국소 피부 조성물
BR112017012025B1 (pt) 2014-12-29 2021-01-12 Kimberly-Clark Worldwide, Inc. emulsão
BR112017011682B1 (pt) 2014-12-29 2021-01-12 Kimberly-Clark Worldwide, Inc. emulsão cosmética
CN107427440A (zh) * 2015-01-28 2017-12-01 国立大学法人九州大学 含有脂质肽型化合物的保湿基材
JP6733680B2 (ja) 2015-04-08 2020-08-05 ディーエスエム アイピー アセッツ ビー．ブイ．Ｄｓｍ Ｉｐ Ａｓｓｅｔｓ Ｂ．Ｖ． 新規のブレンド
WO2016208442A1 (ja) * 2015-06-24 2016-12-29 日産化学工業株式会社 脂質ペプチド型化合物を含むスティック状基材
EP3512867B1 (en) * 2016-09-15 2020-12-16 DSM IP Assets B.V. Novel compounds
CA3075635C (en) * 2017-09-21 2023-07-04 Muhammed Majeed Process for preparing tripeptide containing oleanolic acid and its therapeutic applications thereof
CN108047305B (zh) * 2017-12-08 2021-01-01 陕西慧康生物科技有限责任公司 一种十四烷基氨基丁酰缬氨酰胺基丁酸脲三氟乙酸盐的合成方法
CN107987123B (zh) * 2017-12-11 2021-01-01 陕西慧康生物科技有限责任公司 一种十四烷基氨基丁酰缬氨酰胺基丁酸脲三氟乙酸盐的液相合成方法
CN110423264B (zh) * 2019-08-26 2020-12-01 中国科学院长春应用化学研究所 一种基于活化酯高效制备棕榈酰三肽-5的方法
US20210106506A1 (en) * 2019-10-11 2021-04-15 Elc Management Llc Methods for cosmetic skin remodeling
CA3206148A1 (en) 2021-01-24 2022-07-28 Michael David FORREST Therapeutic modifiers of the reverse mode of atp synthase
IT202200016632A1 (it) * 2022-08-04 2024-02-04 Unifarco S P A Composizioni cosmetiche comprendenti un mix sinergico di attivi con efficacia antietà
WO2024115619A1 (en) 2022-12-02 2024-06-06 Dsm Ip Assets B.V. Mandelic acid salt of palmitoyl lysylvalyl-lysine

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5336477B1 (pt) * 1971-06-07 1978-10-03
DE2641500A1 (de) 1976-09-15 1978-03-16 Siemens Ag Halbleiteranordnung
US4389342A (en) * 1980-04-02 1983-06-21 Perignon Investments, Ltd. Synthetic hormone-like peptides and method for their synthesis
US4686282A (en) * 1983-08-12 1987-08-11 Immunetech, Inc. Immunotherapeutic polypeptide agents which block immune complex binding to immunoglobulin Fc receptors
IT1222437B (it) * 1987-08-04 1990-09-05 Ellem Ind Farmaceutica Tripeptidi utili come immunostimolanti e nella prevenzione delle metastasi e relativo procedimento di preparazione
WO1989012441A1 (en) 1988-06-16 1989-12-28 Procyte Corporation Cosmetic and skin treatment compositions
US5028593A (en) * 1989-08-15 1991-07-02 Board Of Regents, The University Of Texas System Tuftsin analogs
US5593849A (en) * 1993-06-14 1997-01-14 Roy; Benjamin F. Method for detecting antibody against Staphylococcus aureus for replication protein B sequence 275-290 and Arg-Lys-Leu in human body fluids
FR2740453B1 (fr) 1995-10-27 1998-01-16 Bieurope Melanges peptidiques, leur preparation et compositions cosmetiques les contenant
WO1997025999A1 (en) * 1996-01-16 1997-07-24 Rensselaer Polytechnic Institute Peptides for altering osteoblast adhesion
WO1997037228A1 (en) * 1996-03-29 1997-10-09 The Trustees Of Boston University Methods for diagnosing and treating alzheimer's disease
US6333167B1 (en) * 2000-03-10 2001-12-25 American Home Products Corp. Methods and reagents for identifying inhibitors of proteolysis of membrane-associated proteins
FR2810323B1 (fr) 2000-06-16 2002-09-06 Shiseido Int France Utilisation cosmetique d'un lipopeptide
WO2002069884A2 (en) * 2000-11-01 2002-09-12 Zengen, Inc. A sunburn treatment and sunburn prevention method
BRPI0410074B1 (pt) 2003-05-08 2020-03-10 Dsm Ip Assets B.V. Compostos, processo para a preparação e uso dos mesmos, composição, e, processo para o incremento da produção de colágeno e/ou elastina na pele humana e/ou para o retardamento ou o tratamento do envelhecimento da pele

Also Published As

Publication number Publication date
EP1625150B1 (de) 2007-01-03
CA2525476C (en) 2013-07-30
JP4769709B2 (ja) 2011-09-07
ES2280962T3 (es) 2007-09-16
DE502004002556D1 (de) 2007-02-15
US7863417B2 (en) 2011-01-04
RU2346949C2 (ru) 2009-02-20
US20070099842A1 (en) 2007-05-03
WO2004099237A1 (de) 2004-11-18
PL1625150T3 (pl) 2007-05-31
KR20060009007A (ko) 2006-01-27
RU2005134130A (ru) 2006-06-27
CA2525476A1 (en) 2004-11-18
ATE350389T1 (de) 2007-01-15
JP2007523841A (ja) 2007-08-23
JP2011137021A (ja) 2011-07-14
KR101116528B1 (ko) 2012-02-28
US8420778B2 (en) 2013-04-16
EP1625150A1 (de) 2006-02-15
US20110142895A1 (en) 2011-06-16
BRPI0410074B1 (pt) 2020-03-10
EP1625150B9 (de) 2007-06-13

Similar Documents

Publication Publication Date Title
BRPI0410074A (pt) compostos, processo para a preparação e uso dos mesmos, composição, e, processo para o incremento da produção de colágeno e/ou elastina na pele humana e/ou para o retardamento ou o tratamento do envelhecimento da pele
CA2880275C (en) Pharmaceutical or cosmetic composition for treating alopecia
BR0308056A (pt) Composto, pró-droga, método para a produção de um efeito antibacteriano em um animal de sangue quente, uso de um composto, composição farmacêutica, e, processo para a preparação de um composto
MX2007003508A (es) Diaril ureas ciclicas adecuadas como inhibidores de tirosina cinasa.
ATE469161T1 (de) Pyrazolderivat, dieses enthaltende medizinische zusammensetzung, medizinische verwendung davon, und zwischenprodukt für dessen herstellung
BR9916790A (pt) Uso de um composto, composto, processo para amanufatura do mesmo, composição farmacêtica, e,método para produzir um efeito de dano vascularem um animal de sangue quente
ECSP034732A (es) Derivado de fenetanolamina para el tratamiento de enfermedades respiratorias
CO5690599A2 (es) Derivados de 3-(4-aminofenil) tienopirimid-4-ona como antagonistas mch r1 para el tratamiento de obesidad, diabetes, depresion y ansiedad
ECSP066947A (es) Combinaciones farmacológicas que contienen benzoxazina para el tratamiento de enfermedades de las vías respiratorias
BR0202707A (pt) Composição cosmética e/ou dermatológica, utilização de uma composição e de pelo menos um éster n-acilado de aminoácido, e, processo cosmético de bronzeamento ou de amorenamento da pele
BR0315580A (pt) Derivados de metileno uréia
BRPI0507821A (pt) método de esticar o cabelo e uso de uma lactona
WO2006029818A3 (en) Cosmetic compositions containing an hydroxamic acid compound optionally in combination with a retinoid
DE60001544D1 (de) Kreatin, Karnitin und/oder Brenztraubensäure enthaltende kosmetische Zusammensetzungen
EP1634874A4 (en) imidazolidine
ATE427944T1 (de) Isoflavonderivative von tectoridin, deren herstellung und antivirale medikamente, die diese als wirksame bestandteile enthalten
BRPI0407652A (pt) método para acentuar a eficácia de um agente ativo, composição e método para produzir a composição
ES2055366T3 (es) Nuevos derivados de uretano, su preparacion y su aplicacion particularmente como agentes hidratantes en composiciones cosmeticas o farmaceuticas destinadas al tratamiento de las pieles secas.
BRPI0411702A (pt) uso de ácido hialurÈnico para preparar composições para o tratamento de aftas da cavidade oral
AR029618A1 (es) Compuestos de amida , procedimientos para prepararlos, las composiciones farmaceuticas que los contienen y el uso de dichos compuestos para la fabricacion de medicamentos
NO20055754L (no) Kolkisosidanaloger
ES2135695T3 (es) Derivados de aminoacidos y su uso como inhibidores de la fosfolipasa a2.
BR0313971A (pt) Composição de cuidado pessoal, método de cuidado com a pele ou cabelo, e, uso de um componente de álcool primário ramificado
BRPI0411087A (pt) aperfeiçoamentos em ou relacionados a compostos orgánicos
DE602004002366D1 (de) Lipid A und Lipid A enthaltende topische, insbesondere kosmetische, Zusammensetzung

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 3A NUIDADE.

B25A Requested transfer of rights approved

Owner name: DSM NUTRITIONAL PRODUCTS AG (CH)

Free format text: TRANSFERIDO POR FUSAO DE: PENTAPHARM AG

B25A Requested transfer of rights approved

Owner name: DSM IP ASSETS B.V. (NL)

Free format text: TRANSFERIDO DE: DSM NUTRITIONAL PRODUCTS AG

B08G Application fees: restoration [chapter 8.7 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O ART .8O COMBINADO COM ART. 13 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: C07K 7/08 (2006.01), A61K 8/64 (2006.01), A61Q 19/

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 10/03/2020, OBSERVADAS AS CONDICOES LEGAIS.